Specialized manufacturers are gearing up for a robust trade out of generic biosimilar approvals, Kalorama reported last week.
Aurobindo Pharma has submitted an abbreviated new drug application for dolutegravir 50 mg to the Food and Drug Administration for the treatment of HIV.
The Food and Drug Administration has approved Boehringer Ingelheim, Inc.'s Stiolto Respimat (tiotropium bromide and olodaterol), a once-daily inhaler meant to treat obstructed airflow in patients, the company announced Tuesday.
The United Kingdom's Competition and Markets Authority feels that Reckitt-Benckiser acquisition of K-Y personal lubricants may lead to higher prices across the category.
The new Center for Healthcare Regulatory Insight within KPMG's Healthcare and Life Sciences Practice will be led by seasoned regulatory and policy veteran Larry Kocot.
HBO's "Real Sports with Bryant Gumbel" takes a hard look at the sports-nutrition supplements men and women in the military are taking to remain combat ready.
The Retail Industry Leaders Association spoke out in Washington, D.C., this week on the steps retailers are taking to protect against data breaches.
Washington State Governor Jay Inslee has signed into law landmark legislation requiring health insurance carriers to include pharmacists as network providers.
Leading dietary supplement associations on Tuesday spoke to Congressional staffers regarding appropriate herbal supplement tests.
The FDA will review GDUFA in June.